Global Medicinal Cannabis Market

Medicinal Cannabis Comprehensive Study by Type (Flowers, Concentrates, Others), Application (Hospitals, Clinics, Medical Research Centers), Distribution Channel (Dispensaries, Pharmacies, Online Retailers), End Use (Pain management, Neurological health management, Mental health management, Others), Intake (Oral Medications, Topical Medications) Players and Region - Global Market Outlook to 2030

Medicinal Cannabis Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Snapshot:
Medicinal Cannabis is a drug that comes from Indian hemp plants including Cannabis sativa and Cannabis indica, which is been used for medial purpose. Cannabis is also majorly adopted for many recreational purpose which is been used in various forms including ingested in teas, sodas, baked goods and also in vaporizing form. It is been prescribed by physicians for their patients. Medical cannabis can be administered through numerous methods, including capsules, lozenges, oral or dermal sprays, tinctures, dermal patches, cannabis edibles, and vaporizing or smoking dried buds.

Highlights from Medicinal Cannabis Market Study
AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The key Players profiled in the report are Canopy Growth Corporation (Canada), Aurora Cannabis Inc. (Canada), Tikun Olam (Israel), Cannabis Science Inc. (United States), Aphria Inc. (Canada), Maricann Group Inc. (Canada), Tilray Inc. (Canada), VIVO Cannabis Inc. (Canada), Medical Marijuana, Inc. (United States) and STENOCARE (Denmark). Additionally, other players that are part of this comprehensive study are Cronos Group Inc. (Canada), Terra Tech Corp. (United States) and MedMen (United States).

Geographic Breakdown and Segment Analysis
The Global Medicinal Cannabis market presents a comprehensive analysis of the Medicinal Cannabis market by product type (Flowers, Concentrates and Others), by end-user/application (Hospitals, Clinics and Medical Research Centers), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Medicinal Cannabis industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest. For instance, while the holds majority of market share of the Medicinal Cannabis market

Analyst at AMA have segmented the market study of Global Medicinal Cannabis market by Type, Application and Region.

Influencing Trend:
Advancement in Cultivation and Production Methods

Market Growth Drivers:
Growing Medicinal Application of Cannabis and Increasing Legalization of Medicinal Cannabis

Challenges:
High Initial Investments to Set Up Laboratories Are Expect To Challenge the Market

Restraints:
Complex Regulatory Structure for the Usage of Cannabis and High Cost Related Within Cannabis Testing Equipment

Opportunities:
Product Development Via Research and Novel Product Delivery Solutions

Market Developments Activities:
In February 2024 Curaleaf International, part of Curaleaf Holdings and Europe's largest vertically integrated cannabis company, is pleased to announce its acquisition of Can4Med, a prominent pharmaceutical wholesaler specializing in cannabinoid medications in Poland.
In October 2023, Cantourage Group SE (hereinafter a leading European company for the production and distribution of medical cannabis, has signed a long-term supply agreement for medical cannabis with the Swiss cannabis company Astrasana.

Regulatory Insights:
On May 2019, South Africa was the first in Africa region who had federally approved for non-prescription CBD. According to the Health Minister Aaron Motsoaledi amended the country’s medicines and related substances Act 1965, on the removal of cannabidiol preparations for nonserious health claims on the recommendation of South African Health Products Regularity Authority.

The global medicinal cannabis market is highly competitive and consists of some key players. In terms of market share, few of the key players presently dominate the global market. These market players are leveraging on strategic collaboration to intensification their market share and escalation their profitability.

Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Manufacturers, Suppliers and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries

Report Objectives / Segmentation Covered

By Type
  • Flowers
  • Concentrates
  • Others
By Application
  • Hospitals
  • Clinics
  • Medical Research Centers
By Distribution Channel
  • Dispensaries
  • Pharmacies
  • Online Retailers

By End Use
  • Pain management
  • Neurological health management
  • Mental health management
  • Others

By Intake
  • Oral Medications
  • Topical Medications

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Medicinal Application of Cannabis
      • 3.2.2. Increasing Legalization of Medicinal Cannabis
    • 3.3. Market Challenges
      • 3.3.1. High Initial Investments to Set Up Laboratories Are Expect To Challenge the Market
    • 3.4. Market Trends
      • 3.4.1. Advancement in Cultivation and Production Methods
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Medicinal Cannabis, by Type, Application, Distribution Channel, End Use, Intake and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Medicinal Cannabis (Value)
      • 5.2.1. Global Medicinal Cannabis by: Type (Value)
        • 5.2.1.1. Flowers
        • 5.2.1.2. Concentrates
        • 5.2.1.3. Others
      • 5.2.2. Global Medicinal Cannabis by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Medical Research Centers
      • 5.2.3. Global Medicinal Cannabis by: Distribution Channel (Value)
        • 5.2.3.1. Dispensaries
        • 5.2.3.2. Pharmacies
        • 5.2.3.3. Online Retailers
      • 5.2.4. Global Medicinal Cannabis by: End Use (Value)
        • 5.2.4.1. Pain management
        • 5.2.4.2. Neurological health management
        • 5.2.4.3. Mental health management
        • 5.2.4.4. Others
      • 5.2.5. Global Medicinal Cannabis by: Intake (Value)
        • 5.2.5.1. Oral Medications
        • 5.2.5.2. Topical Medications
      • 5.2.6. Global Medicinal Cannabis Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Medicinal Cannabis: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Canopy Growth Corporation (Canada)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Aurora Cannabis Inc. (Canada)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Tikun Olam (Israel)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cannabis Science Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Aphria Inc. (Canada)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Maricann Group Inc. (Canada)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Tilray Inc. (Canada)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. VIVO Cannabis Inc. (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Medical Marijuana, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. STENOCARE (Denmark)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Medicinal Cannabis Sale, by Type, Application, Distribution Channel, End Use, Intake and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Medicinal Cannabis (Value)
      • 7.2.1. Global Medicinal Cannabis by: Type (Value)
        • 7.2.1.1. Flowers
        • 7.2.1.2. Concentrates
        • 7.2.1.3. Others
      • 7.2.2. Global Medicinal Cannabis by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Medical Research Centers
      • 7.2.3. Global Medicinal Cannabis by: Distribution Channel (Value)
        • 7.2.3.1. Dispensaries
        • 7.2.3.2. Pharmacies
        • 7.2.3.3. Online Retailers
      • 7.2.4. Global Medicinal Cannabis by: End Use (Value)
        • 7.2.4.1. Pain management
        • 7.2.4.2. Neurological health management
        • 7.2.4.3. Mental health management
        • 7.2.4.4. Others
      • 7.2.5. Global Medicinal Cannabis by: Intake (Value)
        • 7.2.5.1. Oral Medications
        • 7.2.5.2. Topical Medications
      • 7.2.6. Global Medicinal Cannabis Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Medicinal Cannabis: by Type(USD Million)
  • Table 2. Medicinal Cannabis Flowers , by Region USD Million (2018-2023)
  • Table 3. Medicinal Cannabis Concentrates , by Region USD Million (2018-2023)
  • Table 4. Medicinal Cannabis Others , by Region USD Million (2018-2023)
  • Table 5. Medicinal Cannabis: by Application(USD Million)
  • Table 6. Medicinal Cannabis Hospitals , by Region USD Million (2018-2023)
  • Table 7. Medicinal Cannabis Clinics , by Region USD Million (2018-2023)
  • Table 8. Medicinal Cannabis Medical Research Centers , by Region USD Million (2018-2023)
  • Table 9. Medicinal Cannabis: by Distribution Channel(USD Million)
  • Table 10. Medicinal Cannabis Dispensaries , by Region USD Million (2018-2023)
  • Table 11. Medicinal Cannabis Pharmacies , by Region USD Million (2018-2023)
  • Table 12. Medicinal Cannabis Online Retailers , by Region USD Million (2018-2023)
  • Table 13. Medicinal Cannabis: by End Use(USD Million)
  • Table 14. Medicinal Cannabis Pain management , by Region USD Million (2018-2023)
  • Table 15. Medicinal Cannabis Neurological health management , by Region USD Million (2018-2023)
  • Table 16. Medicinal Cannabis Mental health management , by Region USD Million (2018-2023)
  • Table 17. Medicinal Cannabis Others , by Region USD Million (2018-2023)
  • Table 18. Medicinal Cannabis: by Intake(USD Million)
  • Table 19. Medicinal Cannabis Oral Medications , by Region USD Million (2018-2023)
  • Table 20. Medicinal Cannabis Topical Medications , by Region USD Million (2018-2023)
  • Table 21. South America Medicinal Cannabis, by Country USD Million (2018-2023)
  • Table 22. South America Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 23. South America Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 24. South America Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 25. South America Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 26. South America Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 27. Brazil Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 28. Brazil Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 29. Brazil Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 30. Brazil Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 31. Brazil Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 32. Argentina Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 33. Argentina Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 34. Argentina Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 35. Argentina Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 36. Argentina Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 37. Rest of South America Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 38. Rest of South America Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 39. Rest of South America Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 40. Rest of South America Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 41. Rest of South America Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 42. Asia Pacific Medicinal Cannabis, by Country USD Million (2018-2023)
  • Table 43. Asia Pacific Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 44. Asia Pacific Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 45. Asia Pacific Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 46. Asia Pacific Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 47. Asia Pacific Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 48. China Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 49. China Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 50. China Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 51. China Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 52. China Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 53. Japan Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 54. Japan Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 55. Japan Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 56. Japan Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 57. Japan Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 58. India Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 59. India Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 60. India Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 61. India Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 62. India Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 63. South Korea Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 64. South Korea Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 65. South Korea Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 66. South Korea Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 67. South Korea Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 68. Taiwan Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 69. Taiwan Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 70. Taiwan Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 71. Taiwan Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 72. Taiwan Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 73. Australia Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 74. Australia Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 75. Australia Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 76. Australia Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 77. Australia Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 78. Rest of Asia-Pacific Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 79. Rest of Asia-Pacific Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 80. Rest of Asia-Pacific Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 81. Rest of Asia-Pacific Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 82. Rest of Asia-Pacific Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 83. Europe Medicinal Cannabis, by Country USD Million (2018-2023)
  • Table 84. Europe Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 85. Europe Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 86. Europe Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 87. Europe Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 88. Europe Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 89. Germany Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 90. Germany Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 91. Germany Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 92. Germany Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 93. Germany Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 94. France Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 95. France Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 96. France Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 97. France Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 98. France Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 99. Italy Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 100. Italy Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 101. Italy Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 102. Italy Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 103. Italy Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 104. United Kingdom Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 105. United Kingdom Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 106. United Kingdom Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 107. United Kingdom Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 108. United Kingdom Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 109. Netherlands Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 110. Netherlands Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 111. Netherlands Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 112. Netherlands Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 113. Netherlands Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 114. Rest of Europe Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 115. Rest of Europe Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 116. Rest of Europe Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 117. Rest of Europe Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 118. Rest of Europe Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 119. MEA Medicinal Cannabis, by Country USD Million (2018-2023)
  • Table 120. MEA Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 121. MEA Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 122. MEA Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 123. MEA Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 124. MEA Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 125. Middle East Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 126. Middle East Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 127. Middle East Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 128. Middle East Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 129. Middle East Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 130. Africa Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 131. Africa Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 132. Africa Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 133. Africa Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 134. Africa Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 135. North America Medicinal Cannabis, by Country USD Million (2018-2023)
  • Table 136. North America Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 137. North America Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 138. North America Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 139. North America Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 140. North America Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 141. United States Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 142. United States Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 143. United States Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 144. United States Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 145. United States Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 146. Canada Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 147. Canada Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 148. Canada Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 149. Canada Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 150. Canada Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 151. Mexico Medicinal Cannabis, by Type USD Million (2018-2023)
  • Table 152. Mexico Medicinal Cannabis, by Application USD Million (2018-2023)
  • Table 153. Mexico Medicinal Cannabis, by Distribution Channel USD Million (2018-2023)
  • Table 154. Mexico Medicinal Cannabis, by End Use USD Million (2018-2023)
  • Table 155. Mexico Medicinal Cannabis, by Intake USD Million (2018-2023)
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Medicinal Cannabis: by Type(USD Million)
  • Table 167. Medicinal Cannabis Flowers , by Region USD Million (2025-2030)
  • Table 168. Medicinal Cannabis Concentrates , by Region USD Million (2025-2030)
  • Table 169. Medicinal Cannabis Others , by Region USD Million (2025-2030)
  • Table 170. Medicinal Cannabis: by Application(USD Million)
  • Table 171. Medicinal Cannabis Hospitals , by Region USD Million (2025-2030)
  • Table 172. Medicinal Cannabis Clinics , by Region USD Million (2025-2030)
  • Table 173. Medicinal Cannabis Medical Research Centers , by Region USD Million (2025-2030)
  • Table 174. Medicinal Cannabis: by Distribution Channel(USD Million)
  • Table 175. Medicinal Cannabis Dispensaries , by Region USD Million (2025-2030)
  • Table 176. Medicinal Cannabis Pharmacies , by Region USD Million (2025-2030)
  • Table 177. Medicinal Cannabis Online Retailers , by Region USD Million (2025-2030)
  • Table 178. Medicinal Cannabis: by End Use(USD Million)
  • Table 179. Medicinal Cannabis Pain management , by Region USD Million (2025-2030)
  • Table 180. Medicinal Cannabis Neurological health management , by Region USD Million (2025-2030)
  • Table 181. Medicinal Cannabis Mental health management , by Region USD Million (2025-2030)
  • Table 182. Medicinal Cannabis Others , by Region USD Million (2025-2030)
  • Table 183. Medicinal Cannabis: by Intake(USD Million)
  • Table 184. Medicinal Cannabis Oral Medications , by Region USD Million (2025-2030)
  • Table 185. Medicinal Cannabis Topical Medications , by Region USD Million (2025-2030)
  • Table 186. South America Medicinal Cannabis, by Country USD Million (2025-2030)
  • Table 187. South America Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 188. South America Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 189. South America Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 190. South America Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 191. South America Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 192. Brazil Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 193. Brazil Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 194. Brazil Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 195. Brazil Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 196. Brazil Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 197. Argentina Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 198. Argentina Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 199. Argentina Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 200. Argentina Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 201. Argentina Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 202. Rest of South America Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 203. Rest of South America Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 204. Rest of South America Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 205. Rest of South America Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 206. Rest of South America Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 207. Asia Pacific Medicinal Cannabis, by Country USD Million (2025-2030)
  • Table 208. Asia Pacific Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 209. Asia Pacific Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 210. Asia Pacific Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 211. Asia Pacific Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 212. Asia Pacific Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 213. China Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 214. China Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 215. China Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 216. China Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 217. China Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 218. Japan Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 219. Japan Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 220. Japan Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 221. Japan Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 222. Japan Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 223. India Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 224. India Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 225. India Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 226. India Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 227. India Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 228. South Korea Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 229. South Korea Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 230. South Korea Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 231. South Korea Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 232. South Korea Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 233. Taiwan Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 234. Taiwan Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 235. Taiwan Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 236. Taiwan Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 237. Taiwan Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 238. Australia Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 239. Australia Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 240. Australia Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 241. Australia Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 242. Australia Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 243. Rest of Asia-Pacific Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 244. Rest of Asia-Pacific Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 245. Rest of Asia-Pacific Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 246. Rest of Asia-Pacific Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 247. Rest of Asia-Pacific Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 248. Europe Medicinal Cannabis, by Country USD Million (2025-2030)
  • Table 249. Europe Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 250. Europe Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 251. Europe Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 252. Europe Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 253. Europe Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 254. Germany Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 255. Germany Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 256. Germany Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 257. Germany Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 258. Germany Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 259. France Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 260. France Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 261. France Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 262. France Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 263. France Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 264. Italy Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 265. Italy Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 266. Italy Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 267. Italy Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 268. Italy Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 269. United Kingdom Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 270. United Kingdom Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 271. United Kingdom Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 272. United Kingdom Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 273. United Kingdom Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 274. Netherlands Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 275. Netherlands Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 276. Netherlands Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 277. Netherlands Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 278. Netherlands Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 279. Rest of Europe Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 280. Rest of Europe Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 281. Rest of Europe Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 282. Rest of Europe Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 283. Rest of Europe Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 284. MEA Medicinal Cannabis, by Country USD Million (2025-2030)
  • Table 285. MEA Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 286. MEA Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 287. MEA Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 288. MEA Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 289. MEA Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 290. Middle East Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 291. Middle East Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 292. Middle East Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 293. Middle East Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 294. Middle East Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 295. Africa Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 296. Africa Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 297. Africa Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 298. Africa Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 299. Africa Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 300. North America Medicinal Cannabis, by Country USD Million (2025-2030)
  • Table 301. North America Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 302. North America Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 303. North America Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 304. North America Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 305. North America Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 306. United States Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 307. United States Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 308. United States Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 309. United States Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 310. United States Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 311. Canada Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 312. Canada Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 313. Canada Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 314. Canada Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 315. Canada Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 316. Mexico Medicinal Cannabis, by Type USD Million (2025-2030)
  • Table 317. Mexico Medicinal Cannabis, by Application USD Million (2025-2030)
  • Table 318. Mexico Medicinal Cannabis, by Distribution Channel USD Million (2025-2030)
  • Table 319. Mexico Medicinal Cannabis, by End Use USD Million (2025-2030)
  • Table 320. Mexico Medicinal Cannabis, by Intake USD Million (2025-2030)
  • Table 321. Research Programs/Design for This Report
  • Table 322. Key Data Information from Secondary Sources
  • Table 323. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Medicinal Cannabis: by Type USD Million (2018-2023)
  • Figure 5. Global Medicinal Cannabis: by Application USD Million (2018-2023)
  • Figure 6. Global Medicinal Cannabis: by Distribution Channel USD Million (2018-2023)
  • Figure 7. Global Medicinal Cannabis: by End Use USD Million (2018-2023)
  • Figure 8. Global Medicinal Cannabis: by Intake USD Million (2018-2023)
  • Figure 9. South America Medicinal Cannabis Share (%), by Country
  • Figure 10. Asia Pacific Medicinal Cannabis Share (%), by Country
  • Figure 11. Europe Medicinal Cannabis Share (%), by Country
  • Figure 12. MEA Medicinal Cannabis Share (%), by Country
  • Figure 13. North America Medicinal Cannabis Share (%), by Country
  • Figure 14. Global Medicinal Cannabis share by Players 2023 (%)
  • Figure 15. Global Medicinal Cannabis share by Players (Top 3) 2023(%)
  • Figure 16. Global Medicinal Cannabis share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Canopy Growth Corporation (Canada) Revenue, Net Income and Gross profit
  • Figure 19. Canopy Growth Corporation (Canada) Revenue: by Geography 2023
  • Figure 20. Aurora Cannabis Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 21. Aurora Cannabis Inc. (Canada) Revenue: by Geography 2023
  • Figure 22. Tikun Olam (Israel) Revenue, Net Income and Gross profit
  • Figure 23. Tikun Olam (Israel) Revenue: by Geography 2023
  • Figure 24. Cannabis Science Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Cannabis Science Inc. (United States) Revenue: by Geography 2023
  • Figure 26. Aphria Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 27. Aphria Inc. (Canada) Revenue: by Geography 2023
  • Figure 28. Maricann Group Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 29. Maricann Group Inc. (Canada) Revenue: by Geography 2023
  • Figure 30. Tilray Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 31. Tilray Inc. (Canada) Revenue: by Geography 2023
  • Figure 32. VIVO Cannabis Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 33. VIVO Cannabis Inc. (Canada) Revenue: by Geography 2023
  • Figure 34. Medical Marijuana, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Medical Marijuana, Inc. (United States) Revenue: by Geography 2023
  • Figure 36. STENOCARE (Denmark) Revenue, Net Income and Gross profit
  • Figure 37. STENOCARE (Denmark) Revenue: by Geography 2023
  • Figure 38. Global Medicinal Cannabis: by Type USD Million (2025-2030)
  • Figure 39. Global Medicinal Cannabis: by Application USD Million (2025-2030)
  • Figure 40. Global Medicinal Cannabis: by Distribution Channel USD Million (2025-2030)
  • Figure 41. Global Medicinal Cannabis: by End Use USD Million (2025-2030)
  • Figure 42. Global Medicinal Cannabis: by Intake USD Million (2025-2030)
  • Figure 43. South America Medicinal Cannabis Share (%), by Country
  • Figure 44. Asia Pacific Medicinal Cannabis Share (%), by Country
  • Figure 45. Europe Medicinal Cannabis Share (%), by Country
  • Figure 46. MEA Medicinal Cannabis Share (%), by Country
  • Figure 47. North America Medicinal Cannabis Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Canopy Growth Corporation (Canada)
  • Aurora Cannabis Inc. (Canada)
  • Tikun Olam (Israel)
  • Cannabis Science Inc. (United States)
  • Aphria Inc. (Canada)
  • Maricann Group Inc. (Canada)
  • Tilray Inc. (Canada)
  • VIVO Cannabis Inc. (Canada)
  • Medical Marijuana, Inc. (United States)
  • STENOCARE (Denmark)
Additional players considered in the study are as follows:
Cronos Group Inc. (Canada) , Terra Tech Corp. (United States) , MedMen (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 240 Pages 62 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Medicinal Cannabis Market Quantitative research analysis
Global Medicinal Cannabis Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Due to pricing constraints we only profile limited players in the study that includes a mix list of leaders and emerging players, however for evaluation of market size the coverage includes 100+ players.
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2030
The Study can be customized to meet your requirements. Please connect with our representative, in case you wish to add or remove certain country or profiled players.
  • High Initial Investments to Set Up Laboratories Are Expect To Challenge the Market

Know More About Global Medicinal Cannabis Market Report?

Have a Query? Click Here

Other Related Reports

Narcotic Analgesics Comprehensive Study by Type (Oxycodone, Fentanyl, Hydrocodone, Hydromorphone, Morphine, Methadone, Oxymorphone, Pentazocine), Form (Natural, Semi-Synthetic, Synthetic), Distributi...
$ 3650
Topical Analgesics Comprehensive Study by Type (Prescription Pain Relief, Over-The-Counter Pain Relief), Distribution Channel (Pharmacies & Drug Stores, E-Commerce, Retail & Grocery Stores), Formulat...
$ 3450
Functional Powder Drinks Comprehensive Study by Type (Organic, Conventional), Distribution Channel (Online Stores, Hypermarket/Supermarket, Offline Retail Stores, Other Convenience Stores), Ingredien...
$ 3650
Open Heel Nursing Clogs Comprehensive Study by Type (Wooden Upper Clog, Wooden Soled Clog, Others), Application (Hospitals, Clinics, Ambulatory Surgical Centers), Distribution Channel (Online, Offlin...
$ 3450
Pharmaceuticals Pouch Comprehensive Study by Type (Tamper Evident Pouches, High Barrier / Chemical Resistant Pouches, Breathable Pouches, Non-Peelable Pouches, Peelable Pouch), Application (Pharmaceu...
$ 3750
Eye Health Ingredients Comprehensive Study by Type (Lutein, Zeaxanthin, Vitamin A, Beta-carotene, Bilberry extracts, Other), Application (Pharmaceuticals, Supplements, Beverages, Oils and Fats, Baker...
$ 3650